Tumor necrosis factor (TNF) inhibitors are associated with a reduced risk for recurrent cardiovascular events in patients with radiographic axial spondyloarthritis (axSpA) and a history of ...
Antagonists of tumor necrosis factor (TNF) have revolutionized the treatment of selected inflammatory diseases. In rheumatology, this has been most notable for ankylosing spondylitis, psoriatic ...
a chimeric IgG1κ monoclonal antibody against tumor necrosis factor (TNF). For the first 5 years after his diagnosis he was treated with mesalazine, 6-mercaptopurine and intermittent corticosteroids.